St. Louis-based Ascension has dropped coverage for weight loss drugs such as Wegovy from its employee health plan.
Author: Jakob Emerson
From major positions at Aetna to the president of CVS Caremark, these are 12 top executives that have announced departures from CVS Health or its subsidiaries this year:
Senior care provider ChenMed said July 21 it is restructuring its C-suite and has tapped Steve Nelson to lead day-to-day operations as president.
Value-based physician platform Aledade has partnered with several of the nation's largest payers over the last year.
As insurance premiums continue to rise nationwide, lawsuits from large, self-insured employers are being filed against health insurers in an effort to access complete medical claims data and fulfill fiduciary duties under federal law.
Advertisement
A new bill filed in the Senate July 20 aims to lift the ban on Medicare coverage of weight loss drugs such as Ozempic and Wegovy.
CMS has approved proposals from California and Kentucky for community-based mobile intervention teams to provide behavioral crisis services to Medicaid enrollees.
Medica's President and CEO, John Naylor, is stepping down after leading the company for six years.
A combination of Medicaid redeterminations and a sluggish economy is expected to slow commercial enrollment in the health insurance sector and negatively impact earnings in the second half of 2023, according to a July analysis from Moody's shared with Becker's.
Elevance Health posted double-digit revenue growth and beat investor expectations in the second quarter of 2023, according to the company's earnings report published July 19.